Group of Experimental Biotherapy and Diagnostics, Institute for Regenerative Medicine, World-Class Research Center "Digital Biodesign and Personalized Healthcare", Sechenov First Moscow State Medical University, Moscow, Russia, 119991.
Endocrine Research Laboratory, Department of Zoology, Kutir Post Graduate College, Chakkey, Jaunpur, UP, India.
Mol Cell Biochem. 2022 Feb;477(2):593-604. doi: 10.1007/s11010-021-04308-w. Epub 2021 Dec 1.
Autophagy is the process of recycling and utilization of degraded organelles and macromolecules in the cell compartments formed during the fusion of autophagosomes with lysosomes. During autophagy induction the healthy and tumor cells adapt themselves to harsh conditions such as cellular stress or insufficient supply of nutrients in the cell environment to maintain their homeostasis. Autophagy is currently seen as a form of programmed cell death along with apoptosis and necroptosis. In recent years multiple studies have considered the autophagy as a potential mechanism of anticancer therapy in malignant glioma. Although, subsequent steps in autophagy development are known and well-described, on molecular level the mechanism of autophagosome initiation and maturation using autophagy-related proteins is under investigation. This article reviews current state about the mechanism of autophagy, its molecular pathways and the most recent studies on roles of autophagy-related proteins and their isoforms in glioma progression and its treatment.
自噬是细胞内降解细胞器和大分子的过程,这些细胞器和大分子是在自噬体与溶酶体融合形成的细胞隔室中回收和利用的。在自噬诱导过程中,健康细胞和肿瘤细胞会适应恶劣的条件,如细胞应激或细胞环境中营养物质供应不足,以维持其体内平衡。自噬目前被视为一种程序性细胞死亡形式,与细胞凋亡和坏死性凋亡一起。近年来,多项研究认为自噬是恶性胶质瘤抗癌治疗的一种潜在机制。尽管如此,自噬发展的后续步骤是已知的并且描述得很好,但在分子水平上,使用自噬相关蛋白的自噬体起始和成熟的机制仍在研究中。本文综述了自噬的机制、分子途径以及自噬相关蛋白及其同工型在神经胶质瘤进展及其治疗中的作用的最新研究进展。